Cisco Systems Inc vs Nuwellis Inc — how do they compare? Cisco Systems Inc trades at $115.5 (market cap $462.82B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Cisco Systems Inc is far larger — about 210372.7× Nuwellis Inc's market cap, and Cisco Systems Inc pays a 1.43% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cisco Systems Inc for 86 Days and Nuwellis Inc for 26 Days on average.
| CSCO | NUWE | |
|---|---|---|
Market Cap | $462.82B | $2.20M |
Volume | 17,198,164 | 121,544 |
Sector | Technology | Health |
52-Week High | $130.00 | $146.65 |
52-Week Low | $67.46 | $0.68 |
Typical Hold Time | 86 Days | 26 Days |
Enterprise Value | $476.44B | -$1.52M |
Dividend Yield | 1.43% | — |
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $114.89, down 2.59% on the day, as the stock consolidates near recent highs. The company demonstrates strong fundamentals with Q2 2026 EPS beating expectations at $1.22 versus $1.17, continuing a trend of earnings outperformance. Technical indicators show a bullish moving average trend while oscillators suggest potential near-term consolidation. Recent news highlights Cisco's AI-driven networking momentum with Splunk integration and partnerships with NVIDIA, supporting multi-year growth prospects in AI infrastructure.
Cisco presents a compelling investment case with robust profitability metrics (64.52% gross margin, 27.32% ROE) and analyst consensus pointing to 13% upside to the $129.77 price target. Key risks include competitive pressure in AI security from Datadog and CrowdStrike, and the stock's elevated valuation multiples (P/E 35.25, P/S 7.39) that require continued execution. The company's strong cash flow generation and dividend payments provide shareholder value support.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →